A Phase I Study to Assess the Safety and Immunogenicity of Novel Routes of Administration of Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 and MVA Encoding ME-TRAP.
Phase of Trial: Phase I
Latest Information Update: 26 Apr 2018
At a glance
- Drugs Malaria DNA vaccine (Primary) ; Malaria DNA vaccine (Primary)
- Indications Malaria
- Focus Adverse reactions
- 18 Apr 2018 Planned number of patients changed from 15 to 33.
- 18 Apr 2018 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
- 18 Apr 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.